Julian Abrams, M.D., M.S., ja660@columbia.edu Risk factor for progression in esophageal neoplasia.  In particular, epidemiology, endoscopic treatment modalities and predictive biomarkers for Barrett's esophagus and esophageal adenocarcinoma.   

Domenico Accili, M.D., da230@columbia.edu Insulin resistance in diabetes: Genetics, molecular biology and animal models.

Qais Al-Awqati, M.B., Ch.B., qa1@columbia.edui Developmental biology of the kidney, biogenesis of differentiation of epithelial cells; stem cells in the adult kidney. 

Gerald Appel, M.D., gba2@columbia.edu Treatment of glomerulonephritis, lupus nephritis and the nephrotic syndrome; lipids and renal disease.

Selim Arcasoy, M.D., F.C.C.P., F.A.C.P., sa2059@columbia.edu Lung transplantation and rejection; lung reduction surgery for emphysema; idiopathic pulmonary fibrosis and pulmonary alveolar proteinosis; pulmonary embolism and thrombolytic therapy.

Deborah Davis Ascheim, M.D., dda18@columbia.edu  Investigational therapies for heart failure including pharmacologic, stem cell therapy, gene therapy; investigational surgical techniques and mechanical assist devices for patients with advanced heart failure; altered thyroid hormone metabolism in patients with congestive heart failure.

Arthur Bank, M.D., bank@cancercenter.columbia.edu Gene transfer and expression in bone marrow cells; regulation of human hemoglobin gene expression; molecular biologic analysis of regulation of human globin biosynthesis.

Jonathan Barasch, M.D., Ph.D., jmb4@columbia.edu The ureteric bud secretes proteins that induce nearby mesenchyme to convert to epithelia and form nephrons. The aim of my work is to identify these factors and to determine how they change cell fate in the embryonic kidney.

R. Graham Barr, M.D., Dr.P.H., rgb9@columbia.edu Novel risk factors for asthma and chronic obstructive pulmonary disease (COPD).

Randolph C. Barrows, Jr., M.D., barrows@flux.cpmc.columbia.edu Computerized patient records; information systems in ambulatory care; clinical data warehouses; automated decision support; controlled medical vocabularies; health data modeling; smoking cessation pharmacotherapies and techniques.

Robert C. Basner, M.D., rcb42@columbia.edu Cardiopulmonary regulation during sleep; autonomic and vascular correlates of sleep-disordered breathing.

Paul D. Berk, M.D., pb2158@columbia.edu The Basic transport mechanisms by which fatty acids enter cells and their implications in obesity, fatty liver disease and metabolic syndrome, conducted in mouse and rat models of the human diseases, cell lines in tissue culture and in physiological studies and clinical trials in obese human subjects. 

Jahar Bhattacharya, M.D., D.Phil., jb39@columbia.edu  Two photon and confocal microscopy of the living lung for in situ cell biological studies related to sepsis, pulmonary edema and lung inflammation.  Studies of junctional proteins in cultured lung endothelial cells to understand endothelial barrier regulation. 

Rachel Bijou, M.D., rb540@columbia.edu Clinical research in congestive heart failure.

J. Thomas Bigger, M.D., jtb2@columbia.edu Studies in the prediction and prevention of sudden cardiac death. Studies of the role of the autonomic nervous system in the genesis of malignant ventricular arrhythmias.

John P. Bilezikian, M.D., jpb2@columbia.edu Regulation of signal transduction pathways by parathyroid hormone and parathyroid hormone-related protein. Clinical and basic features of metabolic bone diseases such as primary hyperparathyroidism; osteoporosis in women and men.

Angelo Biviano, M.D., ab542@columbia.edu Clinical cardiac electrophysiology-percutaneous catheter ablations and ICD/Pacemaker implantations.

William Blaner, Ph.D., wsb2@columbia.edu Regulation of vitamin A and retinoic acid metabolism.

Anne Marie Brilliantes, M.D., ab647@columbia.edu Genetic basis of Type 1 and Type 2 diabetes mellitus with specific emphasis on the cellular and molecular biology of the pancreatic beta cell.

Robert S. Brown, Jr., M.D., M.P.H., rb464@columbia.edu Determinants of the cost of orthotopic liver transplantation and the impact of organ allocation strategies on cost and outcome; outcomes including quality of life in chronic liver disease; clinical trials in liver disease and transplantation.

Karen Brudney, M.D.,  kfb2@columbia.edu Clincal research on HIV and tuberculosis in Washington Heights and in the Dominican Republic.

Matthew Burg, Ph. D., mb2358@columbia.edu The role of stress and emotion in CHD related prognosis, and the mechanisms underlying this role.

Daniel Burkhoff, M.D., Ph.D., db59@columbia.edu Mechanics of the failing heart; experimental models of heart failure; angiogenesis.

Stephen M. Canfield, M.D., Ph.D., smc12@columbia.edu T lymphocyte migration; T cell interaction with the extracellular matrix, specifically laminin; molecular structure/function analysis of the 67kD non-integrin laminin binding protein on activated T cells.

Olveen Carrasquillo, M.D., M.P.H., oc6@columbia.edu Health services/health policy research; access to care/the uninsured, racial and ethnic disparities/Latino health; community based participatory research.

Ajai Chari, M.D., ac699@columbia.edu Clinical trials (Phase I,II and II) and translational studies in multiple myeloma (MM) and other plasma cell dyscrasias, e.g., MGUS.  Opportunities to conduct and publish retrospective studies/case series on racial disparities, dual malignancies (lymphomas and MM), HIV-associated paraproteinemia, and autologous stem cell transplantation.

Rita Charon, M.D., Ph.D., rac5@columbia.edu Studies in literature and medicine; imagination as a clinical instrument; patient-doctor discourse; narrative writing in medicine.

Leonard Chess, M.D., lc19@columbia.edu Functional and molecular biological studies of cell surface molecules involved in T cell function. Basic and clinical studies of T cell subsets important in the immunopathogenesis of autoimmune, infectious and neoplastic diseases.

James Cimino, M.D., jjc7@columbia.edu Studies in medical informatics, computerized medical knowledge bases and medical decision-making.

Raphael Clynes, M.D., Ph.D., rc645@columbia.edu Our laboratory studies the role of Fc receptors in autoimmunity and tumor immunity.

David J. Cohen, M.D., djc5@columbia.edu New immunosuppressive therapies in renal transplantaion; renal disease in recipients of heart, liver and lung transplants.

Paolo Colombo, M.D., pcc2001@columbia.edu We conduct translational (clinical/basic) studies to determine the expression of pro-inflammatory genes in the vascular endothelium of patients with diabetes and of patients with heart failure. Using a novel approach, endothelial cells are biopsied from peripheral vessels of patients, and then characterized by real time PCR, flow cytometry and immunofluorescent analysis.

James Coromilas, M.D., jc47@columbia.edu Studies on the mechanisms of ventricular tachycardia. Studies of the effects of antiarrhythmic drugs on re-entrant circuits. Studies on ablation of ventricular tachycardia.  Pathogenesis of Brugada Syndrome, identification of patients at high risk for SCD.

Katherine D. Crew, M.D., M.S., kd59@columbia.edu Breast cancer prevention and control.

Jeanine D’Armiento, M.D., Ph.D., jmd12@columbia.edu Understanding the mechanisms of smoke induced injury in disease.

Jonathan David, M.D., FACP, FACG, jd165@columbia.edu Colon cancer screening; cost issues in healthcare, using endoscopy as a model.

Karina W. Davidson, Ph.D., kd2124@columbia.edu Behavioral Medicine randomized controlled trials with cardiology patients.

Mario Deng, M.D., md785@columbia.edu Outcomes evaluation of medical and surgical therapies in advanced heart failure and the underlying molecular and cellular pathophysiology, with specific emphasis on the interleuken-6 cytokine system.

Angela DiMango, M.D., ead3@columbia.edu Clinical research includes treatment and management of patients with chronic obstructive airway disease (COPD and asthma); member of the National Emphysema Treatment Trial (NETT); caring for patients with pulmonary complications related to cancer and its treatment.

Marco R. DiTullio, M.D., md42@columbia.edu Echocardiographic assessment of cardiac embolic sources for ischemic stroke, especially aortic plaques. Applications of echocardiography to epidemiologic studies on cardioembolic stroke.

Jay F. Dobkin, M.D., jfd2@columbia.edu Pathogenesis of pneumococcal infection in AIDS; epidemiology of tuberculosis associated with AIDS.

Andrew J. Einstein, M.D., Ph.D., phf2103@columbia.edu Cardiac imaging; radiation safety in cardiology.

Phillip Factor, D.O., phf2103@columbia.edu Mechanisms of pulmonary edema clearance, role and regulation of lung Bü2-adrenergic receptors, treatment of acute lung injury, gene therapies for acute and acquired diseases.

Anthony Ferrante Jr., M.D., Ph.D., awf7@columbia.edu Large increases in fat mass lead to obesity and adversely alter blood pressure, insulin sensitivity, serum lipid profiles and cardiac function. Research has uncovered a critical role for myeloid cells in the development of metabolic consequences of obesity, and focuses on understanding the role of macrophages in the development of insulin resistance, diabetes and non-alcoholic fatty liver disease.

Robert L. Fine, M.D., rlf20@columbia.edu Translational cancer research into the mechanisms of cancer drug resistance in the lab to the clinical implementation of novel therapeutic trials to improve outcome based on lab research.

Michael J. Flamm, M.D., Ph.D., mjf3@columbia.edu Retroviral gene transfer in the treatment of paroxysmal noctural hemoglobinuria.

Robert Foronjy, M.D., rff5@columbia.edu Emphysema.

Pamela Freda, M.D., puf1@columbia.edu Clinical studies of patients with pituitary tumors.

Harold Frucht, M.D., hf2011@columbia.edu Gastrointestinal malignancies and pre-malignant conditions, specifically hereditary syndromes and cancer genetics, prevention and early detection; acid hypersecretory states and GI hormone excess syndromes. Translational research in gastrointestinal cancer biology.

Edward Gelmann, M.D., gelmanne@columbia.edu Prostate cancer pathogenesis and the role of a ubiquitous prostate tumor suppressor protein NKX3.1., which is specific for the prostate and influences cell growth, differentiation and DNA repair.  This protein is important in several pathways that are known to be important in the transition cells undergo when they acquire the malignant phenotype.

Ali Ghavari, M.D., ag2239@columbia.edu Molecular genetics of renal diseases, in particular glomerular disorders in humans and rodent models.

Elsa-Grace V. Giardina, M.D., evg1@columbia.edu Heart disease in women; mechanism of action of estrogen and other drugs to reduce cardiac risk in women.  Metabolic syndrome in women and families.

Rachel J. Gordon, M.D., M.P.H., rj216@columbia.edu Studying the molecular epidemiology and pathogenesis of ventricular assist device infections with Staphylococcus epidermidis.

Victor Grann, M.D., M.P.H., vrg2@columbia.edu Health outcomes, cost-effectiveness and decision analysis, quality of life, and disparities of cancer care and prevention.

William A. Gray, M.D., wg2131@columbia.edu Peripheral vascular intervention, percutaneous valve therapy, non-surgical modalities for stroke prevention (carotid stenting and patent foramen ovale (PFO) closure), and research into preventing the reoccurrence of disease following successful angioplasty or stenting.

Henry N. Ginsberg, M.D., hmg1@columbia.edu Assembly and secretion of lipoproteins from cultured liver cells. Studies of insulin resistance and dyslipidemia in transgenic mouse models. Regulation of lipid and lipoprotein metabolism in humans.

Robin S. Goland, M.D., rsg2@columbia.edu Several NIH multi-center clinical trials for treatment of Type 1 and Type 2 Diabetes in adolescents and youth.

Ira J. Goldberg, M.D., ijg3@columbia.edu Regulation of plasma triglyceride metabolism, lipid uptake into tissues and models of diabetic cardiovascular disease.  These studies utilize cells and genetically modified mouse models.  The human diseases that are modeled include atherosclerosis, diabetic cardiomyopathy and obesity-induced insulin resistance. 

Rochelle Goldsmith, Ph.D., rlg11@columbia.edu Exercise physiology; mechanisms of exercise limitation in heart failure; exercise training and left ventricular remodeling.

Peter H.R. Green, M.D., pg11@columbia.edu Celiac disease: clinical presentation, manifestations and complications; genetic analysis, immunologic mechanisms and pathogenesis.

Steven Greenberg, M.D., smg8@columbia.edu Molecular studies of macrophage cytoskeleton. Signal transduction of Fc receptors. Molecular biology of phagocytosis.

Scott Hammer, M.D., smh48@columbia.edu Antiretroviral therapy; HIV drug resistance; pathogenesis of HIV infection.

Dawn Hershman, M.D., M.S., dlh23@columbia.edu Clinical trials in breast cancer treatment, prevention, supportive care and cancer survivorship.  Research in quality of care and health services research.

Shunichi Homma, M.D., sh23@columbia.edu Cardiac studies with various ultrasound methods.  Therapeutic application of ultrasound.  Epidemiological studies of cardioembilic stroke risk factors.   

Evelyn M. Horn, M.D., emh3@columbia.edu Neurohormonal mechanisms of adrenergic dysfunction in congestive heart failure; clinical studies in heart failure. Clinical research in primary pulmonary hypertension.

George Hripcsak, M.D., gh13@columbia.edu Medical informatics: Medical knowledge-based systems; sharing electronic knowledge across institutions; electronic medical record.

Li-Shin Huang, Ph.D., lh99@columbia.edu Genetic regulation of assembly and secretion of apoB-containing lipoproteins, precursors of LDL. Molecular mechanisms underlying the development of fatty livers associated with insulin resistance and diabetes. 

Hong Jiang, M.D., Ph.D., hj4@columbia.edu Cellular and molecular mechanisms of immunoregulation by the CD8+ and CD4+T cells in peripheral tolerance; molecular biologic analysis of interaction between CD8+ and CD4+ T cells; CD8+ T cell mediated control of autoimmunity.

Andrew Joe, M.D., akj3@columbia.edu Evaluating cancer prevention agents and identifying surrogate tumor markers for use in targeted clinical chemoprevention; ongoing translational, patient-oriented projects, in which I am investigating Barrett’s Esophagus and African-American Breast Cancer.

Ulrich P. Jorde, M.D., upj1@columbia.edu Pharmacotherapy of congestive heart failure.  Device therapy of congestive heart failure.

Daniel Kass, M.D., Ph.D., jk181@olumbia.edu Idiopathic Pulmonary Fibrosis:  Molecular biology, animal models, and novel approaches to treatment.

Judith Korner, M.D., Ph.D., jk181@columbia.edu Clinical studies and basic research in the pathogenesis and treatment of obesity, insulin resistance and diabetes.

Stavroula Kousteni, Ph.D., sk2836@columbia.edu Interactions between hormones, cytokines, kinases and bone.  Cellular and molecular mechanisms of the pathogenesis of osteoporosis due to estrogen deficiency and old age; mechanisms of parathyroid hormone and steroid hormone receptor action; anabolic bone therapies; and the contribution of anti-oxidant defense mechanisms and longevity-related pathways to the preservation of bone mass.

Donald Landry, M.D., Ph.D., dwl1@columbia.edu Drug discovery including small molecules and artificial enzymes; vasopressin deficiency in vasodilatory states.

Rafael Lantigua, M.D., ral4@columbia.edu Mentoring minority investigators in aging research; genetics of Alzheimer’s Disease.

David Lederer, M.D., M.S., dl427@columbia.edu Outcomes in advanced lung disease and lung transplantation.  Clinical trials. 

Marianne Legato, M.D., mjl2@columbia.edu Delineating the differences in men and women’s normal physiology and in their unique experience of the same diseases as a function of their biological sex.

Rudolph L. Leibel, M.D., rl232@columbia.edu Molecular genetics and energetics of obesity and Type 2 diabetes in rodents and humans.

Barron H. Lerner, M.D., bhl5@columbia.edu Medical ethics and the history of medicine, especially regarding breast cancer, celebrity patients, drunk driving and the role of media in publicizing medical advances.

Charles J. Lightdale, M.D., cjl18@columbia.edu Diagnosis and treatment of Barrett’s esophagus and early esophageal cancer; studies in magnification and enhanced endoscopy, biomarkers, chemoprevention, endoscopic mucosal resection, radiofrequency ablation, and cryoablation. 

Franklin Lowy, M.D., fl189@columbia.edu Research involves the pathogenesis and transmission of Staphylococcus aureus.

Jeremy Luban, M.D., jl45@columbia.edu Molecular biology of HIV-1 replication and pathogenesis; regulation of T cell cytokine production.

Jose Luchsinger, M.D., jal94@columbia.edu Relationship between cardiovascular risk factors and cognition. Relationship between diet and cognition.

Arthur Magun, M.D., amm3@columbia.edu Clinical trials in the treatment of chronic hepatitis.

Donna Mancini, M.D., dmm31@columbia.edu Cardiac transplantation; immunosuppressive surveillance and therapy. Mechanisms of exercise intolerance in heart failure.

Andrew R. Marks, M.D., arm42@columbia.edu Molecular cardiology; structure and function of calcium channels and their regulation in the pathogenesis of heart failure and cardiac arrhythmias.

Steven Marx, M.D., sm460@columbia.edu Ion channels in the heart and their regulation by kinases and phosphatases through the formation of macromolecular complexes.

Igor Matushansky, M.D., Ph.D., jm17@columbia.edu Stem cells and their relationship to sarcomagenesis; investigational (differentiation based) therapy for sarcomas; genetics, molecular biology and animal models of sarcomas.

Mathew Maurer, M.D., msm10@columbia.edu Syncope; isolated systolic hypertension; diastolic heart failure.

Roger A. Maxfield, M.D., ram7@columbia.edu Multicenter clinical trials of bronchoscopic treatment for advanced emphysema. 

Rachel Miller, M.D., rlm14@columbia.edu Clinical, translational and basic science research on mechanisms in asthma and allergies, including prenatal and early postnatal exposures and asthma outcomes, role of air pollution, gene by environment interactions, epigenetic mechanisms. 

Lori Mosca, M.D., M.P.H., Ph.D., ljm10@columbia.edu Clinical trials and outcomes research in cardiovascular disease prevention and women’s health; novel technologies to screen for heart disease; effect of preventive therapies on endothelial function.

Alan J. Moskowitz, M.D., ajm4@columbia.edu Clinical evaluative research of new interventions for cardiovascular and cerebrovascular disease.  Particular interest in measuring survival, quality of life, and economic impact of mechanical circulatory support for advanced heart failure and therapeutic approaches to brain arteriovenous malformations.

Alfred I. Neugut, M.D., Ph.D., ain1@columbia.edu Studies in cancer epidemiology and cancer screening.

Juan Oliver, M.D., jao7@columbia.edu Renal stem cells; kidney development; septic shock and vasopressin.

Ariel Pablos-Mendez, M.D., M.P.H., ap39@columbia.edu Epidemiology of tuberculosis. Clinical preventive services.  Global health.  Health systems. e-Health.

Walter Palmas-Meilinger, M.D., wp56@columbia.edu Telemedicine for prevention of chronic diseases.  Prevention of cardiovascular diseases. Identification and causes of subclinical atherosclerosis.  Monitoring and management of hypertension.

Ramon E. Parsons, M.D., Ph.D., rep15@columbia.edu Genetic and biochemical analysis of breast cancer.

Alessandra Pernis, M.D., abp1@columbia.edu Molecular mechanisms of B cell development and function.

Daniel P. Petrylak, M.D., dpp5@columbia.edu Clinical and laboratory research in the mechanism of hormonal and chemotherapeutic resistance in prostate and bladder cancer.

Thomas Pickering, M.D., D.Phil. tp2114@columbia.edu Behavioral aspects of hypertension and heart disease.

Charles Powell, M.D., cap6@columbia.edu Translational studies on functional genomics of lung cancer and mesothelioma.

Leroy E. Rabbani, M.D., ler8@columbia.edu Pathophysiology and treatment of acute myocardial infarction and acute coronary syndromes.

Jai Radhakrishnan, M.D., M.R.C.P., jr55@columbia.edu Glomerular disease. Medical education.  Informatics.

Ravi Ramasamy, Ph.D., rr260@columbia.edu Metabolic basis of ischemic injury and heart failure; molecular and cellular impact of polyol pathway.

James A. Reiffel, M.D., jar2@columbia.edu Diagnosis and treatment of cardiac rhythm disorders (arrhythmias).

Carlos Jose Rodriguez, M.D., MPH, FACC, cjr10@columbia.edu Echocardiography and cardiovascular disease epidemiology; particularly hypertensive heart disease among underrepresented minorities.

Michael Rosenbaum, M.D., mr475@columbia.edu Regulation of body weight and the pathogenesis of type 2 diabetes in adults and children.

David J. Rothman, Ph.D., djr5@columbia.edu The ethics of human experimentation, in the U.S. and developing countries; the social implications of genetic enhancement technologies; the social and ethical issues in organ donation and transplantation.  The idea and practice of medical professionalism.

Chris Schindler, M.D., Ph.D., cw54@columbia.edu Cytokine signal transduction and the role it plays in immunity, atherosclerosis and asthma.

Neil Schluger, M.D., ns311@columbia.edu The use of novel diagnostics for latent tuberculosis.  Clinical trials of treatments for latent and active tuberculosis. 

Robert Schwabe, M.D., rfs2102@columbia.edu Inflammatory signals in liver fibrosis and liver cancer, hepatic stellate cell biology, endocannabinoids in the liver. 

Allan Schwartz, M.D., as20@columbia.edu Transcatheter therapy of valvular heart disease. 

Elizabeth Shane, M.D., es54@columbia.edu Postmenopausal osteoporosis.  Pathophysiology, mechanisms and management of secondary osteoporosis including glucocorticoids, antiepileptic drugs, celiac disease, bone disease associated with cardiac, lung, renal, liver and bone marrow transplantation, chronic kidney disease, breast and prostate cancer and their therapies.  Primary and secondary hyperparathyroidism and other metabolic bone diseases.  Vitamin D. Novel imaging techniques to assess bone quality.  Osteoporosis in young men and women.

Steven Shea, M.D., ss35@columbia.edu Studies in cardiovascular epidemiology and cardiovascular disease prevention.

Michael M. Shen, Ph.D., mshen@columbia.edu Pattern formation and cellular differentiation during early mouse embryogenesis; prostate stem cells, organogenesis and regeneration; mouse models of prostate cancer.

Daichi Shimbo, M.D., ds2231@columbia.edu Biological mechanisms underlying psychosocial and behavioral and cardiovascular events.  Echocardiographic evidence of mechanical dyssynchrony in heart failure patients.

Shonni J. Silverberg, M.D., sjs5@columbia.edu Pathophysiology and clinical studies of osteoporosis, primary hyperparathyroidism and other metabolic bone diseases.

Ethel S. Siris, M.D., es27@columbia.edu Paget’s disease of bone, osteoporosis and metabolic bone diseases.

Robert J. Sommer, M.D., rs2463@columbia.edu Interventional Catheterization for Adult Congenital Heart Disease; Patent Foramen Ovale: Stroke/Migraine.

Susan F. Steinberg, M.D., sfs1@columbia.edu Cardiomyocyte beta-adrenergic receptors; basic cellular mechanisms and novel strategies to treat heart failure; protease-activated receptor signal transduction in cardiomyocytes, a link between inflammation and cardiomyopathy.

Leonard Stern, M.D., ls38@columbia.edu Clinical trials testing for dialysis technology and treatments in end stage renal disease; clinical trials for pharmaceuticals in patients with chronic kidney disease; clinical trials evaluating contributing factors towards survival in patients on peritoneal dialysis: clinical trials in collaboration with the dental school evaluating the prevalence of periodontal disease in patients on chronic dialysis. 

Peter D. Stevens, M.D., pds5@columbia.edu New technique and outcomes research in pancreaticobiliary diseases and GI bleeding.

Milan N. Stojanovic, Ph.D., mns18@columbia.edu Oligonucleotide-based fluorescent probes for small molecules and proteins; directed movement of catalytic nanoassemblies; recognition-triggered drug delivery systems; decision-making molecular networks.

Ira Tabas, M.D., Ph.D., iat1@columbia.edu Mechanisms and consequences of atherosclerotic foam cell formation.

Alan Tall, M.D., art1@columbia.edu Plasma lipoproteins; cell and molecular biology of atherosclerosis.

Robert N. Taub, M.D., Ph.D., rnt1@columbia.edu Drug discovery; molecular biology of mesothelioma and sarcoma; clinical trials in sarcoma, mesothelioma and melanoma.

Simon J. Tsiouris, M.D., M.P.H., st326@columbia.edu TB and TB/HIV epidemiology in resource limited settings, TB and LTBI diagnostics, novel antimicrobials for bacterial and fungal infections.

Silke Vogel, Ph.D., sv98@columbia.edu Retinoid metabolism, adipogenesis and insulin resistance.  Animal models, ex vivo and in vitro analysis, molecular biology.

Marcella Walker, M.D., mad2037@columbia.edu Racial differences in bone density and other aspects of bone quality.

Jie Wang, M.D., Ph.D., jw147@columbia.edu Experimental models of heart failure; role of coronary circulation in disease regression.

Timothy C. Wang, M.D., tcw21@columbia.edu Pathogenesis of gastric, colonic and pancreatic cancer; carcinogenesis; cancer stem cells; adult stem cells; inflammation and cancer; tumor microenvironment, mouse models of cancer.

Sharon Wardlaw, M.D., sw22@columbia.edu Neuroendocrine control of pituitary function; hypothalamic neuropeptides and regulation of energy homeostasis.

Michelle Warren, M.D., mpw1@columbia.edu Effects of exercise and weight loss on the hypothalamic-pituitarygonadal axis and the metabolic signals to the GnRH pulse generator, and on the development of osteopenia in women. Treatment of the menopausal woman. Effects of puberty on behavior.

Hal Wasserman, M.D., hsw1@columbia.edu Adjunctive treatments for myocardial infarction; reperfusion therapy; transplant-related coronary artery disease.

I. Bernard Weinstein, M.D., ibw1@columbia.edu Molecular mechanisms of carcinogenesis, utilizing cell culture systems and molecular genetics; growth factors and signal transduction.

Giora Weisz, M.D., gw2128@columbia.edu Clinical research in interventional cardiology.

Carrie Welch, Ph.D., cbw13@columbia.edu Using a mouse genetics approach to identify new genes underlying susceptibility to atherosclerosis and thrombosis.

Robert Winchester, M.D., rjw8@columbia.edu The genetic basis of susceptibility to autoimmune disease and the mechanisms responsible for triggering and mediating autoimmune injury.   

Howard Worman, M.D., hjw14@columbia.edu Pathobiology of diseases caused by mutations in genes encoding nuclear envelope proteins, such as Emery-Dreifuss muscular dystrophy, Dunnigan-type familial partial lipodystrophy and Hutchinson-Gilgord progeria syndrome.